Evidence map›Paper›PMID 8929950›Full record

ArticleJournal of medical genetics1996

The clinical, molecular, and pathological characterisation of a family with two cases of lethal perinatal type 2 Gaucher disease.

E Sidransky, N Tayebi, B K Stubblefield, W Eliason, A Klineburgess, G P Pizzolato, J N Cox, J Porta, A Bottani, C D DeLozier-Blanchet

Open access · bronzeAbstract readCase ReportsComparative Study
In one paragraph

Article in Journal of medical genetics, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Lysosomal storage diseases.Translational science of rare diseases · 2017
    Review
  3. The clinical management of Type 2 Gaucher disease.Molecular genetics and metabolism · 2015
    Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Type 2 Gaucher disease: the collodion baby phenotype revisited.Archives of disease in childhood. Fetal and neonatal edition · 2000
    Article
  10. Article
  11. Mice with type 2 and 3 Gaucher disease point mutations generated by a single insertion mutagenesis procedure.Proceedings of the National Academy of Sciences of the United States of America · 1998
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

E SidranskyNational Institute of Mental Health, NIH, Bethesda, MD, USA.
N Tayebi
B K Stubblefield
W Eliason
A Klineburgess
G P Pizzolato
J N Cox
J Porta
A Bottani
C D DeLozier-Blanchet
National Institute of Mental Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has recently been emphasised that a subset of patients with type 2 Gaucher disease die in the neonatal period. This report describes an Afghani family with two conceptuses having severe, prenatally detected Gaucher disease. Mutational analysis showed that the family carried a known complex allele which included mutations at amino acids L444P, A456P, and V460V. Although glucocerebrosidase RNA was present, an affected fetus had virtually no glucocerebrosidase cross reactive material on western analyses. The severe clinical course and pathology observed in these patients resemble that of the null allele Gaucher mouse, and suggest that the absence of glucocerebrosidase activity results in early death.

Indexed as

AfghanistanAllelesAnimalsBase SequenceCells, CulturedDNA Mutational AnalysisFatal OutcomeFibroblastsGaucher DiseaseGenes, LethalGenes, RecessiveGlucosylceramidaseHumansInfant, NewbornMaleMiceGlucosylceramidase

Identifiers

PMID8929950
PMCPMC1051839
OpenAlexW2044005191

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.